☰

Pamela Rojas de Santiago - Publications

Affiliations: 
Universidad de Chile, Santiago, Región Metropolitana, Chile 
Website:
https://ocrahope.org/bio/pamela-rojas-de-santiago/
Tree Info Grants Similar researchers PubMed Report error

4 high-probability publications. We are testing a new system for linking publications to authors. You can help! If you notice any inaccuracies, please sign in and mark papers as correct or incorrect matches. If you identify any major omissions or other inaccuracies in the publication list, please let us know.

Year Citation  Score
2023 Sato S, Gillette M, de Santiago PR, Kuhn E, Burgess M, Doucette K, Feng Y, Mendez-Dorantes C, Ippoliti PJ, Hobday S, Mitchell MA, Doberstein K, Gysler SM, Hirsch MS, Schwartz L, et al. LINE-1 ORF1p as a candidate biomarker in high grade serous ovarian carcinoma. Scientific Reports. 13: 1537. PMID 36707610 DOI: 10.1038/s41598-023-28840-5  0.589
2022 Oróstica KY, Saez-Hidalgo J, de Santiago PR, Rivas S, Contreras S, Navarro G, Asenjo JA, Olivera-Nappa Á, Armisén R. Total mutational load and clinical features as predictors of the metastatic status in lung adenocarcinoma and squamous cell carcinoma patients. Journal of Translational Medicine. 20: 373. PMID 35982500 DOI: 10.1186/s12967-022-03572-8  0.606
2022 Morales F, Pérez P, Tapia JC, Lobos-González L, Herranz JM, Guevara F, de Santiago PR, Palacios E, Andaur R, Sagredo EA, Marcelain K, Armisén R. Increase in ADAR1p110 activates the canonical Wnt signaling pathway associated with aggressive phenotype in triple negative breast cancer cells. Gene. 819: 146246. PMID 35122924 DOI: 10.1016/j.gene.2022.146246  0.475
2020 de Santiago PR, Blanco A, Morales F, Marcelain K, Harismendy O, Herrera MS, Armisén R. Immune-related IncRNA LINC00944 responds to variations in ADAR1 levels and it is associated with breast cancer prognosis. Life Sciences. 118956. PMID 33383047 DOI: 10.1016/j.lfs.2020.118956  0.62
Show low-probability matches.